Table 2.
Differentially abundant serum proteins identified in longitudinal cohorts of vivax malaria patients.
| Sl NO. | Protein name | Uniprot Accession ID | Gene Name | Unique peptides† | (FEB/HC) | (DEF/HC) | (CON/HC) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Fold-change | Adjusted p-value | Fold-change | Adjusted p-value | Fold-change | Adjusted p-value | |||||
| 1 | Apolipoprotein A-II | P02652 | APOA2 | 8 | 0.41 | 0.047 | 0.47 | 0.073 | 0.64 | 0.244 |
| 2 | Apolipoprotein A-I$* | P02647 | APOA1 | 36 | 0.42 | 0.001 | 0.48 | 0.008 | 0.64 | 0.054 |
| 3 | Heparin cofactor 2 | P05546 | SERPIND1 | 7 | 0.44 | 0.005 | 0.39 | 0.001 | 0.50 | 0.019 |
| 4 | Apolipoprotein C-I | P02654 | APOC1 | 3 | 0.45 | 0.003 | 0.40 | 0.00003 | 0.46 | 0.0002 |
| 5 | Haptoglobin$* | P00738 | HP | 17 | 0.47 | 0.024 | 0.68 | 0.049 | 1.09 | 0.704 |
| 6 | Inter-alpha-trypsin inhibitor heavy chain H2$ | P19823 | ITIH2 | 18 | 0.49 | 0.008 | 0.41 | 0.003 | 0.51 | 0.025 |
| 7 | Serum paraoxonase/ arylesterase 1 | P27169 | PON1 | 5 | 0.64 | 0.074 | 0.54 | 0.007 | 0.69 | 0.122 |
| 8 | Inter-alpha-trypsin inhibitor heavy chain H1 | P19827 | ITIH1 | 15 | 0.65 | 0.021 | 0.45 | 0.000 | 0.66 | 0.013 |
| 9 | Conserved oligomeric Golgi complex subunit 4 | Q9H9E3 | COG4 | 8 | 0.66 | 0.148 | 0.55 | 0.018 | 0.85 | 0.360 |
| 10 | Afamin | P43652 | AFM | 13 | 0.67 | 0.033 | 0.73 | 0.131 | 0.64 | 0.021 |
| 11 | Apolipoprotein C-III | P02656 | APOC3 | 5 | 0.68 | 0.031 | 0.68 | 0.041 | 0.73 | 0.209 |
| 12 | Kininogen-1 | P01042 | KNG1 | 6 | 0.69 | 0.081 | 0.63 | 0.006 | 0.68 | 0.113 |
| 13 | Fibronectin | P02751 | FN1 | 22 | 0.72 | 0.030 | 0.58 | 0.005 | 0.63 | 0.009 |
| 14 | Inter-alpha-trypsin inhibitor heavy chain H4 | Q14624 | ITIH4 | 24 | 0.72 | 0.043 | 0.63 | 0.056 | 0.71 | 0.035 |
| 15 | Complement C5 | P01031 | C5 | 8 | 0.73 | 0.067 | 0.67 | 0.038 | 0.68 | 0.023 |
| 16 | Complement C3 | P01024 | C3 | 89 | 0.74 | 0.159 | 0.66 | 0.032 | 0.79 | 0.171 |
| 17 | Clusterin | P10909 | CLU | 12 | 0.75 | 0.106 | 0.68 | 0.003 | 0.71 | 0.092 |
| 18 | Apolipoprotein B-100 | P04114 | APOB | 145 | 0.77 | 0.030 | 0.63 | 0.002 | 0.76 | 0.029 |
| 19 | Serum amyloid P-component | P02743 | APCS | 3 | 0.78 | 0.216 | 0.62 | 0.025 | 0.70 | 0.086 |
| 20 | Complement C4-A | P0C0L4 | C4A | 7 | 0.85 | 0.104 | 0.73 | 0.014 | 1.10 | 0.703 |
| 21 | Hemopexin$* | P02790 | HPX | 12 | 1.22 | 0.05 | 1.12 | 0.163 | 1.00 | 0.295 |
| 22 | Apolipoprotein E* | P02649 | APOE | 11 | 1.24 | 0.05 | 1.16 | 0.045 | 0.87 | 0.715 |
| 23 | Alpha-1-acid glycoprotein 1 | P02763 | ORM1 | 8 | 1.25 | 0.139 | 1.49 | 0.041 | 1.46 | 0.088 |
| 24 | Biotinidase | P43251 | BTD | 2 | 1.30 | 0.045 | 1.12 | 0.555 | 1.10 | 0.685 |
| 25 | Alpha-1-antichymotrypsin$ | P01011 | SERPINA3 | 26 | 1.42 | 0.036 | 1.28 | 0.379 | 1.22 | 0.096 |
| 26 | Alpha-1-antitrypsin$ | P01009 | SERPINA1 | 40 | 1.47 | 0.115 | 1.51 | 0.004 | 1.50 | 0.164 |
| 27 | Leucine-rich alpha-2-glycoprotein$ | P02750 | LRG1 | 7 | 1.83 | 0.005 | 1.63 | 0.037 | 1.49 | 0.047 |
| 28 | Cell growth-regulating nucleolar protein | Q9NX58 | LYAR | 13 | 1.85 | 0.056 | 2.10 | 0.044 | 2.26 | 0.157 |
| 29 | Serum amyloid A-1$* | P0DJI8 | SAA1 | 6 | 2.49 | 0.008 | 1.60 | 0.023 | 2.15 | 0.018 |
| 30 | Carbonic anhydrase 1 | P00915 | CA1 | 4 | 2.61 | 0.014 | 1.37 | 0.207 | 1.43 | 0.048 |
| 31 | Hemoglobin subunit alpha | P69905 | HBA1 | 7 | 2.63 | 0.006 | 1.49 | 0.025 | 1.33 | 0.032 |
| 32 | Hemoglobin subunit beta | P68871 | HBB | 8 | 2.70 | 0.003 | 1.66 | 0.057 | 1.47 | 0.047 |
| 33 | Hemoglobin subunit delta | P02042 | HBD | 7 | 3.77 | 0.005 | 1.89 | 0.101 | 1.83 | 0.036 |
| 34 | C-reactive protein | P02741 | CRP | 4 | 3.91 | 0.003 | 6.69 | 0.006 | 2.45 | 0.001 |
| 35 | Hemoglobin subunit zeta | P02008 | HBZ | 5 | 4.83 | 0.011 | 1.88 | 0.023 | 2.21 | 0.041 |
#This is a partial list for some selected candidates (p < 0.05 in at least one comparison) identified in iTRAQ and 2D-DIGE-based quantitative proteomics analysis; complete lists of the identified differentially abundant proteins are provided under supplementary information (Tables S6, S7 and S8). †Median value for the identified unique peptides in different biological replicates is represented. $Differential abundances for these candidates are also identified in 2D-DIGE (details are provided in Table S6). *Differential serum abundances of these proteins are validated by ELISA (details are provided in Table S13A).